Solving the nuclear isotopes shortage

Accelerator facilities suggested for hospitals

At the end of January, the of Concerned Scientists issued a call to improve supplies of nuclear isotopes, which is used in medical imaging. In the face of no firm plans to solve these problems, Tom Ruth, of TRIUMF, Vancouver, Canada, has proposed both short and long-term visions for the future in an Essay in the science journal Nature.

Four-fifths of the most widely-used radionuclide comes from just two nuclear reactor facilities: one in the Netherlands; one in Canada. Due to the short half-life of the isotope, stockpiling for more than a couple of days is impossible. Unexpected closures of both of these aging facilities over the past 18 months caused panic and the cancellation of medical procedures. In addition, both facilities make use of highly enriched uranium, seen by some as a terrorism risk.
Ruth’s solution is to replace reactor-made isotopes with ones made from an accelerator. This is cheaper and safer, as it does not involve highly enriched uranium, but requires the Canadian government to take steps to retain its role as a world leader in nuclear medicine. His vision for the future involves equipping more hospitals with their own accelerator facilities, so that different isotopes can be used to produce clearer, better medical images.
Details: www.nature.com/nature. Essay publication date: 29/1/09.
Tom Ruth: truth@triumf.ca

01.03.2009

Related articles

Photo

Article • Institutional setup guide at SNMMI 2024

How to establish a hospital theranostics treatment centre

The nuclear medicine global market is projected to see a significant increase in the coming years, with the lion's share being attributed to radiotherapeutics. So, how to set up a dedicated…

Photo

News • Evaluating tadiotheranostic targets

Endometrial cancer: new markers for PET imaging

Researchers explored two promising new biomarkers as potential radiotheranostic targets for endometrial cancer. This could help identify patients who are likely to respond to targeted therapeutics.

Photo

News • Fluorescent 18F-PET imaging

Dual-mode PET tracer lets surgeons see – and hear – prostate cancer

Tracer molecules serve to provide visual guidance in nuclear medicine, but a new molecule could give surgeons additional audio cues to help them locate prostate cancer tumors and metastases.

Related products

Subscribe to Newsletter